Terug
26
20
6
37
26
24
Ook genoteerd als
NCSYF
OTC
Dagbereik
€ 116,94
€ 120,59
52-Weeksbereik
€ 94,65
€ 180,61
Volume
322.297
50D / 200D Gem.
€ 114,58
/
€ 132,88
Vorige Slotkoers
€ 118,36
Koershistorie
Financiële Trends
Sectorvergelijking
vs Technology sector mediaan (620 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 11,5 | 12,6 |
| P/B | 1,8 | 3,0 |
| ROE % | 16,5 | 8,9 |
| Net Margin % | 20,8 | 5,6 |
| Rev Growth 5Y % | 11,5 | 9,2 |
| D/E | 0,0 | 0,3 |
Belangrijkste Punten
Revenue grew 11,49% annually over 5 years — strong growth
Earnings grew 39,40% over the past year
ROE of 16,53% — decent returns on equity
Net margin of 20,78% shows strong profitability
Debt/Equity of 0,04 — conservative balance sheet
Generating 703,16M in free cash flow
Groei
Revenue Growth (5Y)
11,49%
Revenue (1Y)8,54%
Earnings (1Y)39,40%
FCF Growth (3Y)21,38%
Kwaliteit
Return on Equity
16,53%
ROIC12,25%
Net Margin20,78%
Op. Margin22,23%
Veiligheid
Debt / Equity
0,04
Current Ratio1,55
Interest Coverage0,00
Waardering
P/E Ratio
11,54
P/B Ratio1,84
EV/EBITDA10,46
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,54% | Revenue Growth (3Y) | 11,74% |
| Earnings Growth (1Y) | 39,40% | Earnings Growth (3Y) | 35,04% |
| Revenue Growth (5Y) | 11,49% | Earnings Growth (5Y) | 32,66% |
| Profitability | |||
| Revenue (TTM) | 2,97B | Net Income (TTM) | 616,96M |
| ROE | 16,53% | ROA | 12,08% |
| Gross Margin | 66,41% | Operating Margin | 22,23% |
| Net Margin | 20,78% | Free Cash Flow (TTM) | 703,16M |
| ROIC | 12,25% | FCF Growth (3Y) | 21,38% |
| Safety | |||
| Debt / Equity | 0,04 | Current Ratio | 1,55 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 11,54 | P/B Ratio | 1,84 |
| P/S Ratio | 2,40 | PEG Ratio | 0,27 |
| EV/EBITDA | 10,46 | Dividend Yield | 0,00% |
| Market Cap | 7,12B | Enterprise Value | 6,90B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,97B | 2,74B | 2,38B | 2,18B | 1,92B |
| Net Income | 616,96M | 442,59M | 338,30M | 265,95M | 199,22M |
| EPS (Diluted) | 9,75 | 6,76 | 5,11 | 4,00 | 2,98 |
| Gross Profit | 1,97B | 1,83B | 1,61B | 1,50B | 1,30B |
| Operating Income | 660,02M | 545,95M | 435,23M | 335,17M | 263,91M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,11B | 5,30B | 5,12B | 4,85B | 4,71B |
| Total Liabilities | 1,23B | 1,69B | 1,76B | 1,80B | 1,87B |
| Shareholders' Equity | 3,88B | 3,59B | 3,34B | 3,04B | 2,83B |
| Total Debt | 163,86M | 563,60M | 782,97M | 777,46M | 925,91M |
| Cash & Equivalents | 379,38M | 481,71M | 511,80M | 529,60M | 378,66M |
| Current Assets | 1,38B | 2,50B | 2,31B | 2,42B | 2,30B |
| Current Liabilities | 887,61M | 1,47B | 1,12B | 1,14B | 1,27B |
Strategiescores
This stock passed the criteria for 6 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#880 of 1024
Custom
Capital Light Compounder
#194 of 213
#589 of 658
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#264 of 326
Custom
Balanced Risk
#141 of 148
Custom
Lower Risk
#133 of 136
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026
Ingestapt
Capital Light Compounder
Mar 24, 2026
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026
Ingestapt
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026
Ingestapt
Balanced Risk
Mar 24, 2026
Ingestapt
Lower Risk
Mar 24, 2026